Table 5.
Proportion of nutrition abnormalities via nutrition assessment tools
| NAT measure | ||||
| Proportion of non-sarcopenic patients n (%) | Proportion of sarcopenic patients n (%) | Study ID | ||
| Sarcopenia | 49 (54.4) | 41 (45.6) | Adams et al[33] | |
| 42 (58.3) | 30 (41.7) | Bamba et al[9] | ||
| 125 (72.3) | 48 (27.7) | Csontos et al[30] | ||
| 25 (30.5) | 57 (69.5) | Cushing et al[34] | ||
| 51 (73.9) | 18 (26.1) | Fujikawa et al[29] | ||
| 47 (67.1) | 30 (38.9) | O’Brien et al[31] | ||
| 134 (75.3) | 44 (24.7) | Pedersen et al[12] | ||
| 99 (66.4) | 50 (33.6) | Thiberge et al[32] | ||
| 115 (56.4) | 89 (43.6) | Zhang et al[11] | ||
| 44 (35.1) | 70 (61.4) | Zhang et al[10] | ||
| Comprehensive RD/GI Assessment | Proportion of patients not at risk n (%) | Proportion of patients at risk of malnutrition n (%) | Study ID | |
| 87 (79.1) | 23 (20.9) | Haskey et al[35] | ||
| SGA | Proportion of SGA A | Proportion of SGA B | Proportion of SGA C | Study ID |
| 8 (11.1) | 37 (51.4) | 27 (37.5%) | Bamba et al[9] | |
| 8 (20.0) | 17 (42.5) | 15 (37.5%) | Takaoka et al[13] | |
| 48 (87.3) | 7 (12.7) | Jansen et al[8] | ||
NAT: Nutrition assessment tools; RD/GI: Registered dietitian/Gastroenterologist.